BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9495236)

  • 1. Nation-wide breast cancer screening in The Netherlands: results of initial and subsequent screening 1990-1995. National Evaluation Team for Breast Cancer Screening.
    Fracheboud J; de Koning HJ; Beemsterboer PM; Boer R; Hendriks JH; Verbeek AL; van Ineveld BM; de Bruyn AE; van der Maas PJ
    Int J Cancer; 1998 Mar; 75(5):694-8. PubMed ID: 9495236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nation-wide breast cancer screening in The Netherlands: support for breast-cancer mortality reduction. National Evaluation Team for Breast Cancer Screening (NETB).
    De Koning HJ; Fracheboud J; Boer R; Verbeek AL; Collette HJ; Hendriks JH; van Ineveld BM; de Bruyn AE; van der Maas PJ
    Int J Cancer; 1995 Mar; 60(6):777-80. PubMed ID: 7896444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nationwide breast cancer screening fully accomplished; results from the implementation phase 1990-1997. National Evaluation Team for Breast Cancer Screening].
    Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1124-9. PubMed ID: 10876708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term breast cancer screening in Nijmegen, The Netherlands: the nine rounds from 1975-92.
    Otten JD; van Dijck JA; Peer PG; Straatman H; Verbeek AL; Mravunac M; Hendriks JH; Holland R
    J Epidemiol Community Health; 1996 Jun; 50(3):353-8. PubMed ID: 8935470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nation-wide data on screening performance during the transition to digital mammography: observations in 6 million screens.
    van Luijt PA; Fracheboud J; Heijnsdijk EA; den Heeten GJ; de Koning HJ;
    Eur J Cancer; 2013 Nov; 49(16):3517-25. PubMed ID: 23871248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interval cancers in the Dutch breast cancer screening programme.
    Fracheboud J; de Koning HJ; Beemsterboer PM; Boer R; Verbeek AL; Hendriks JH; van Ineveld BM; Broeders MJ; de Bruyn AE; van der Maas PJ
    Br J Cancer; 1999 Nov; 81(5):912-7. PubMed ID: 10555768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer screening; cost-effective in practice?
    De Koning HJ
    Eur J Radiol; 2000 Jan; 33(1):32-7. PubMed ID: 10674787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for breast cancer in Nijmegen. Report of 6 screening rounds, 1975-1986.
    Peeters PH; Verbeek AL; Hendriks JH; van Bon MJ
    Int J Cancer; 1989 Feb; 43(2):226-30. PubMed ID: 2917799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nationwide breast cancer screening programme fully implemented in The Netherlands.
    Fracheboud J; de Koning HJ; Boer R; Groenewoud JH; Verbeek AL; Broeders MJ; van Ineveld BM; Hendriks JH; de Bruyn AE; Holland R; van der Maas PJ;
    Breast; 2001 Feb; 10(1):6-11. PubMed ID: 14965550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammography screening in the county of Fyn. November 1993-December 1999.
    Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E
    APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in incidence and tumour grade in screen-detected ductal carcinoma in situ and invasive breast cancer.
    Luiten JD; Voogd AC; Luiten EJT; Duijm LEM
    Breast Cancer Res Treat; 2017 Nov; 166(1):307-314. PubMed ID: 28748346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-specific effectiveness of the Nijmegen population-based breast cancer-screening program: assessment of early indicators of screening effectiveness.
    Peer PG; Holland R; Hendriks JH; Mravunac M; Verbeek AL
    J Natl Cancer Inst; 1994 Mar; 86(6):436-41. PubMed ID: 8120918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in surgery for screen-detected and interval breast cancers in a national screening programme.
    Nederend J; Duijm LE; Louwman MW; Roumen RM; Jansen FH; Voogd AC
    Br J Surg; 2014 Jul; 101(8):949-58. PubMed ID: 24828281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of digital screening mammography and screen-film mammography in the early detection of clinically relevant cancers: a multicenter study.
    Bluekens AM; Holland R; Karssemeijer N; Broeders MJ; den Heeten GJ
    Radiology; 2012 Dec; 265(3):707-14. PubMed ID: 23033499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammographic screening after the age of 65 years: early outcomes in the Nijmegen programme.
    van Dijck J; Verbeek A; Hendriks J; Holland R; Mravunac M
    Br J Cancer; 1996 Dec; 74(11):1838-42. PubMed ID: 8956803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dutch digital breast cancer screening: implications for breast cancer care.
    Timmers JM; den Heeten GJ; Adang EM; Otten JD; Verbeek AL; Broeders MJ
    Eur J Public Health; 2012 Dec; 22(6):925-9. PubMed ID: 22158996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in breast cancer mortality due to the introduction of mass screening in The Netherlands: comparison with the United Kingdom.
    van den Akker-van Marle E; de Koning H; Boer R; van der Maas P
    J Med Screen; 1999; 6(1):30-4. PubMed ID: 10321368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results from the Ontario breast screening program, 1990-1995.
    Libstug AR; Moravan V; Aitken SE
    J Med Screen; 1998; 5(2):73-80. PubMed ID: 9718525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impressive time-related influence of the Dutch screening programme on breast cancer incidence and mortality, 1975-2006.
    Otten JD; Broeders MJ; Fracheboud J; Otto SJ; de Koning HJ; Verbeek AL
    Int J Cancer; 2008 Oct; 123(8):1929-34. PubMed ID: 18688863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.